129 related articles for article (PubMed ID: 16374117)
1. False-positive In-111 DTPA octreotide scintigraphy resulting from lung abscess in a patient with metastatic neuroendocrine pancreatic neoplasm.
Valero M; Boán JF; Rodriguez-Spiteri N; Torre W; Richter JA
Clin Nucl Med; 2006 Jan; 31(1):20-2. PubMed ID: 16374117
[No Abstract] [Full Text] [Related]
2. [Scintigraphy atlas of somatostatin receptors in neuroendocrine tumors of the pancreas and carcinoid tumors].
Banzo J; Prats E; Razola P; García S; Alonso V; Velilla J; Freile E; Benito JL; García F; Ubieto MA; Tardín L; Abós MD
Rev Esp Med Nucl; 2005; 24(4):278-92. PubMed ID: 16122413
[No Abstract] [Full Text] [Related]
3. Use of 111In-DTPA-octreotide scintigraphy in the diagnosis of neuroendocrine and non-neuroendocrine tumors of the lung. Preliminary results.
Oliaro A; Filosso PL; Bello M; Casadio C; Angusti T; Masaneo I; Maggi G; Bisi G
J Cardiovasc Surg (Torino); 1997 Jun; 38(3):313-5. PubMed ID: 9219485
[TBL] [Abstract][Full Text] [Related]
4. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
Wiedenmann B; Bäder HM; Scherubl H; Fett U; Zimmer T; Hamm B; Koppenhagen K; Riecken EO
Semin Oncol; 1994 Oct; 21(5 Suppl 13):29-32. PubMed ID: 7992077
[No Abstract] [Full Text] [Related]
5. Ulcer of the Duodenum Caused by a Pancreatic Neuroendocrine Tumor in an Adolescent.
Grossi V; Bezler N; Sayej W
Clin Gastroenterol Hepatol; 2017 Jan; 15(1):A45-A46. PubMed ID: 27613258
[No Abstract] [Full Text] [Related]
6. Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.
Shi W; Johnston CF; Buchanan KD; Ferguson WR; Laird JD; Crothers JG; McIlrath EM
QJM; 1998 Apr; 91(4):295-301. PubMed ID: 9666953
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary results on the use of scintigraphy with radiolabelled octreotide as diagnostic method in neuroendocrine and nonendocrine neoplasms of the lung].
Oliaro A; Filosso PL; Bellò M; Casadio C; Muni A; Angusti T; Masaneo I; Bisi G; Maggi G
Minerva Chir; 1997 Nov; 52(11):1335-8. PubMed ID: 9489331
[TBL] [Abstract][Full Text] [Related]
8. [The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors].
Chiti A; Spinelli A; Bombardieri E
Radiol Med; 1997 Oct; 94(4):362-70. PubMed ID: 9465244
[No Abstract] [Full Text] [Related]
9. 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.
Anderson CJ; Dehdashti F; Cutler PD; Schwarz SW; Laforest R; Bass LA; Lewis JS; McCarthy DW
J Nucl Med; 2001 Feb; 42(2):213-21. PubMed ID: 11216519
[TBL] [Abstract][Full Text] [Related]
10. Localization of gastroenteropancreatic neuroendocrine tumors with 111indium-pentetreotide scintigraphy.
Pauwels S; Leners N; Fiasse R; Jamar F
Semin Oncol; 1994 Oct; 21(5 Suppl 13):15-20. PubMed ID: 7992075
[No Abstract] [Full Text] [Related]
11. Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results.
Krenning EP; Kwekkeboom DJ; Oei HY; de Jong RJ; Dop FJ; Reubi JC; Lamberts SW
Ann N Y Acad Sci; 1994 Sep; 733():416-24. PubMed ID: 7978890
[No Abstract] [Full Text] [Related]
12. False-positive Ga-67 citrate scan secondary to an inguinal hernia.
Fong W; Lim E
Clin Nucl Med; 2002 Jul; 27(7):534-5. PubMed ID: 12072788
[No Abstract] [Full Text] [Related]
13. [Scintigraphy of somatostatin receptors in the diagnosis and staging of neuroendocrine tumors of the digestive tract and pancreas].
Banzo J; Abós MD; Prats E; García F; Razola P
Rev Esp Med Nucl; 2000 Jun; 19(3):225-41. PubMed ID: 11062088
[No Abstract] [Full Text] [Related]
14. Physiological Uptake in the Pancreatic Head on Somatostatin Receptor Scintigraphy Using [111In-DTPA]Octreotide: Incidence and Mechanism.
Brabander T; Teunissen J; Kwekkeboom D
Clin Nucl Med; 2017 Jan; 42(1):15-19. PubMed ID: 27775943
[TBL] [Abstract][Full Text] [Related]
15. Broncho-biliary fistula secondary to biliary obstruction and lung abscess in a patient with pancreatic neuro-endocrine tumor.
Panda D; Aggarwal M; Yadav V; Kumar S; Mukund A; Baghmar S
J Egypt Natl Canc Inst; 2016 Jun; 28(2):117-21. PubMed ID: 26994644
[TBL] [Abstract][Full Text] [Related]
16. Detectability of hypervascularity in early dynamic PET depends on tracer kinetics: 18 F-FDG versus 68 Ga-DOTATOC in hepatic NET metastasis.
Sänger P; Schierz JH; Marlowe RJ; Freesmeyer M
Liver Int; 2014 Jan; 34(1):161. PubMed ID: 23663248
[No Abstract] [Full Text] [Related]
17. Differential diagnosis of a hepatic mass by
León-Asuero-Moreno I; Calvo-Morón MC; Garcia-Gomez FJ; Sabatel-Hernández G; Castro-Montaño J
Cir Esp (Engl Ed); 2019; 97(6):355-357. PubMed ID: 30449568
[No Abstract] [Full Text] [Related]
18. Pancreatic endocrine tumor with neoplastic venous thrombus and bilobar liver metastasis. A case report.
Barbier L; Turrini O; Sarran A; Delpero JR
J Visc Surg; 2010 Feb; 147(1):e58-62. PubMed ID: 20587379
[TBL] [Abstract][Full Text] [Related]
19. Peritumoural steatosis in metastatic "non-functioning" neuroendocrine tumour of the pancreas.
Borghei P; Pan Z; Berland LL
Clin Radiol; 2012 Oct; 67(10):1027-9. PubMed ID: 22554699
[No Abstract] [Full Text] [Related]
20. Resolution of Hyperreninemia, Secondary Hyperaldosteronism, and Hypokalemia With 177Lu-DOTATATE Induction and Maintenance Peptide Receptor Radionuclide Therapy in a Patient With Pancreatic Neuroendocrine Tumor.
Makis W; McCann K; Riauka TA; McEwan AJ
Clin Nucl Med; 2015 Nov; 40(11):880-4. PubMed ID: 26359564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
